| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;99:1788-1794.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis
From the Department of Cardiovascular Medicine, University of Oxford, UK (B.Z., S.Y., H.W., A.M.H.); INSERM SC 7, Paris, France (S.H., F.C); Atherosclerosis Research Unit, King Gustaf V Research Institute, Stockholm, Sweden (P.E., A.H.); Gaubius Laboratory TNO-PG, Leiden, The Netherlands (M.M.); MONICA Project, Belfast, UK (A.E.); MONICA Project, Strasbourg, France (D.A.); and MONICA Project, Lille, France (G.L.).
Correspondence to Dr Shu Ye, Wessex Human Genetics Institute, University of Southampton School of Medicine, Southampton General Hospital, Duthie Building (Mp 808), Tremona Rd, Southampton SO16 6YD, United Kingdom. E-mail Shu.Ye{at}soton.ac.uk
Background—Gelatinase B, a matrix metalloproteinase that has proteolytic activity against connective tissue proteins, has been suggested to be important in the connective tissue remodeling processes associated with atherogenesis and plaque rupture. This study tested the hypothesis that sequence variation in the promoter region of the gelatinase B gene influences its expression, predisposing individuals carrying certain genetic variants to more severe atherosclerosis.
Methods and Results—Single-strand conformation polymorphism analysis was carried out to search the promoter region of the gene encoding gelatinase B for naturally occurring genetic variation. As a result, an unreported common polymorphism was detected, which arose from a cytosine (C) to thymidine (T) transition at position -1562 relative to the start of transcription. Transient transfection experiments and DNA-protein interaction assays indicated that the T allele had a higher promoter activity than the C allele, which appeared to be due to preferential binding of a putative transcription repressor protein to the C allelic promoter. A sample of 584 male patients with myocardial infarction and 645 age-matched male healthy control subjects were genotyped. The allele frequencies were not significantly different between the cases and control subjects. However, in 374 patients with available angiographic data, 26% of those carrying 1 or 2 copies of the T allele had >50% stenosis in 3 coronary arteries, whereas only 15% of C/C homozygotes had triple-vessel disease.
Conclusions—These data suggest that this functional genetic variation influences gelatinase B gene promoter activity in an allele-specific manner and has an effect on atherosclerotic phenotype.
Key Words: metalloproteinases • atherosclerosis • genetics • molecular biology
This article has been cited by other articles:
 |
|
 |
|
  Z. Mallat Matrix Metalloproteinase-8 and the Regulation of Blood Pressure, Vascular Inflammation, and Atherosclerotic Lesion Growth Circ. Res., October 23, 2009; 105(9): 827 - 829. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Smolonska, C. Wijmenga, D. S. Postma, and H. M. Boezen Meta-analyses on Suspected Chronic Obstructive Pulmonary Disease Genes: A Summary of 20 Years' Research Am. J. Respir. Crit. Care Med., October 1, 2009; 180(7): 618 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. O'Mara, J. A. Clements, and A. B. Spurdle The Use of Predictive or Prognostic Genetic Biomarkers in Endometrial and Other Hormone-Related Cancers: Justification for Extensive Candidate Gene Single Nucleotide Polymorphism Studies of the Matrix Metalloproteinase Family and their Inhibitors Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2352 - 2365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tang, J. Zhu, L. Chen, L. Chen, S. Zhang, and J. Lin Associations of Matrix Metalloproteinase-9 Protein Polymorphisms with Lymph Node Metastasis but not Invasion of Gastric Cancer Clin. Cancer Res., May 1, 2008; 14(9): 2870 - 2877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hughes, O. Agbaje, R. L. Bowen, D. L. Holliday, J. A. Shaw, S. Duffy, and J. L. Jones Matrix Metalloproteinase Single-Nucleotide Polymorphisms and Haplotypes Predict Breast Cancer Progression Clin. Cancer Res., November 15, 2007; 13(22): 6673 - 6680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Cockle, N. Gopichandran, J. J. Walker, M. I. Levene, and N. M. Orsi Matrix Metalloproteinases and Their Tissue Inhibitors in Preterm Perinatal Complications Reproductive Sciences, October 1, 2007; 14(7): 629 - 645. [Abstract] [PDF]
|
|
|
|
 |
|
 F. G. Spinale Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function Physiol Rev, October 1, 2007; 87(4): 1285 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Kader, J. Liu, L. Shao, C. P. Dinney, J. Lin, Y. Wang, J. Gu, H. B. Grossman, and X. Wu Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness Clin. Cancer Res., May 1, 2007; 13(9): 2614 - 2620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Sampsonas, A. Kaparianos, D. Lykouras, K. Karkoulias, and K. Spiropoulos DNA sequence variations of metalloproteinases: their role in asthma and COPD Postgrad. Med. J., April 1, 2007; 83(978): 244 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Flex, E. Gaetani, A. S. Proia, G. Pecorini, G. Straface, F. Biscetti, G. Fioroni, A. Sabusco, R. Flore, P. Tondi, et al. Analysis of functional polymorphisms of metalloproteinase genes in persons with vascular dementia and Alzheimer's disease. J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2006; 61(10): 1065 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Yasmin, C. M. McEniery, K. M. O'Shaughnessy, P. Harnett, A. Arshad, S. Wallace, K. Maki-Petaja, B. McDonnell, M. J. Ashby, J. Brown, et al. Variation in the Human Matrix Metalloproteinase-9 Gene Is Associated With Arterial Stiffness in Healthy Individuals Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1799 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Takemura, S. Yoshida, S. Kennedy, M. Deguchi, N. Ohara, and T. Maruo Matrix Metalloproteinase-1 and -9 Promoter Polymorphisms Are Not Associated With an Increased Risk of Uterine Leiomyomas in a Japanese Population Reproductive Sciences, April 1, 2006; 13(3): 232 - 236. [Abstract] [PDF]
|
|
|
|
 |
|
 C. M. Dollery and P. Libby Atherosclerosis and proteinase activation Cardiovasc Res, February 15, 2006; 69(3): 625 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ye Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome Cardiovasc Res, February 15, 2006; 69(3): 636 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shan, Z. Lian-Fu, D. Hui, G. Wei, W. Na, J. Xia, and L. Yan Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China Mol. Hum. Reprod., January 1, 2006; 12(1): 35 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Ito, S. Nagai, T. Handa, S. Muro, T. Hirai, M. Tsukino, and M. Mishima Matrix Metalloproteinase-9 Promoter Polymorphism Associated with Upper Lung Dominant Emphysema Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1378 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Newby and J. L. Johnson Genetic Strategies to Elucidate the Roles of Matrix Metalloproteinases in Atherosclerotic Plaque Growth and Stability Circ. Res., November 11, 2005; 97(10): 958 - 960. [Full Text] [PDF]
|
|
|
|
 |
|
 S R Johnson TIMP-1 in asthma: guilty by association Thorax, August 1, 2005; 60(8): 617 - 618. [Full Text] [PDF]
|
|
|
|
|
|
F Lose, P J Thompson, D Duffy, G A Stewart, and M-A Kedda A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women Thorax, August 1, 2005; 60(8): 623 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kyriakou, C. Hodgkinson, D. E. Pontefract, S. Iyengar, W. M. Howell, Y.-k. Wong, P. Eriksson, and S. Ye Genotypic Effect of the -565C>T Polymorphism in the ABCA1 Gene Promoter on ABCA1 Expression and Severity of Atherosclerosis Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 418 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Yasmin, S. Wallace, C. M. McEniery, Z. Dakham, P. Pusalkar, K. Maki-Petaja, M. J. Ashby, J. R. Cockcroft, and I. B. Wilkinson Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 372 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Newby Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture Physiol Rev, January 1, 2005; 85(1): 1 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hulkkonen, M. Pertovaara, J. Antonen, A. Pasternack, M. Hurme, P. Pollanen, and T. Lehtimaki Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome Rheumatology, December 1, 2004; 43(12): 1476 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al. Functional Genomics of Lung Disease Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2/S1): S1 - S81. [Full Text] [PDF]
|
|
|
|
|
|
T. L. Medley, T. J. Cole, A. M. Dart, C. D. Gatzka, and B. A. Kingwell Matrix Metalloproteinase-9 Genotype Influences Large Artery Stiffness Through Effects on Aortic Gene and Protein Expression Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1479 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G Spinale Matrix metalloproteinase gene polymorphisms in heart failure: new pieces to the myocardial matrix puzzle Eur. Heart J., April 2, 2004; 25(8): 631 - 633. [Full Text] [PDF]
|
|
|
|
|
|
F. Mizon-Gerard, P. de Groote, N. Lamblin, X. Hermant, J. Dallongeville, P. Amouyel, C. Bauters, and N. Helbecque Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction Eur. Heart J., April 2, 2004; 25(8): 688 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wagner, B. Kluge, J. A. Koziol, A. J. Grau, and C. Grond-Ginsbach MMP-9 Polymorphisms Are Not Associated With Spontaneous Cervical Artery Dissection Stroke, March 1, 2004; 35 (3): e62 - e64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Montano, C. Beccerril, V. Ruiz, C. Ramos, R. H. Sansores, and G. Gonzalez-Avila Matrix Metalloproteinases Activity in COPD Associated With Wood Smoke Chest, February 1, 2004; 125(2): 466 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Montaner, I. Fernandez-Cadenas, C. A. Molina, J. Monasterio, J. F. Arenillas, M. Ribo, M. Quintana, P. Chacon, A. L. Andreu, and J. Alvarez-Sabin Safety Profile of Tissue Plasminogen Activator Treatment Among Stroke Patients Carrying a Common Polymorphism (C-1562T) in the Promoter Region of the Matrix Metalloproteinase-9 Gene Stroke, December 1, 2003; 34(12): 2851 - 2855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. D Defawe, A. Colige, C. A Lambert, C. Munaut, P. Delvenne, C. M Lapiere, R. Limet, B. V Nusgens, and N. Sakalihasan TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas Cardiovasc Res, October 15, 2003; 60(1): 205 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B Jones, D. C Sane, and D. M Herrington Matrix metalloproteinases: A review of their structure and role in acute coronary syndrome Cardiovasc Res, October 1, 2003; 59(4): 812 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Harendza, D. H. Lovett, U. Panzer, Z. Lukacs, P. Kuhnl, and R. A. K. Stahl Linked Common Polymorphisms in the Gelatinase A Promoter Are Associated with Diminished Transcriptional Response to Estrogen and Genetic Fitness J. Biol. Chem., May 30, 2003; 278(23): 20490 - 20499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Blankenberg, H. J. Rupprecht, O. Poirier, C. Bickel, M. Smieja, G. Hafner, J. Meyer, F. Cambien, L. Tiret, and for the AtheroGene Investigators Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease Circulation, April 1, 2003; 107(12): 1579 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Chua, M. E. Melish, Q. Yu, R. Yanagihara, K. S. Yamamoto, and V. R. Nerurkar Elevated Levels of Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 during the Acute Phase of Kawasaki Disease Clin. Vaccine Immunol., March 1, 2003; 10(2): 308 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Atkinson and R. M. Senior Matrix Metalloproteinase-9 in Lung Remodeling Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 12 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fornoni, Y. Wang, O. Lenz, L. J. Striker, and G. E. Striker Association of a Decreased Number of d(CA) Repeats in the Matrix Metalloproteinase-9 Promoter with Glomerulosclerosis Susceptibility in Mice J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2068 - 2076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Loftus and M. Thompson The role of matrix metalloproteinases in vascular disease Vascular Medicine, May 1, 2002; 7(2): 117 - 133. [Abstract] [PDF]
|
|
|
|
|
|
P. E. Ferrand, S. Parry, M. Sammel, G. A. Macones, H. Kuivaniemi, R. Romero, and J. F. Strauss III A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans Mol. Hum. Reprod., May 1, 2002; 8(5): 494 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Joos, J.-Q. He, M. B. Shepherdson, J. E. Connett, N. R. Anthonisen, P. D. Pare, and A. J. Sandford The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function Hum. Mol. Genet., March 1, 2002; 11(5): 569 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. S. Galis and J. J. Khatri Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly Circ. Res., February 22, 2002; 90(3): 251 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Pollanen, P. J. Karhunen, J. Mikkelsson, P. Laippala, M. Perola, A. Penttila, K. M. Mattila, T. Koivula, and T. Lehtimaki Coronary Artery Complicated Lesion Area Is Related to Functional Polymorphism of Matrix Metalloproteinase 9 Gene: An Autopsy Study Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1446 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhang, S. Dhillon, I. Geary, W. M. Howell, F. Iannotti, I. N.M. Day, and S. Ye Polymorphisms in Matrix Metalloproteinase-1, -3, -9, and -12 Genes in Relation to Subarachnoid Hemorrhage Stroke, September 1, 2001; 32(9): 2198 - 2202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E.J.M. Creemers, J. P.M. Cleutjens, J. F.M. Smits, and M. J.A.P. Daemen Matrix Metalloproteinase Inhibition After Myocardial Infarction: A New Approach to Prevent Heart Failure? Circ. Res., August 3, 2001; 89(3): 201 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Opdenakker, P. E. Van den Steen, B. Dubois, I. Nelissen, E. Van Coillie, S. Masure, P. Proost, and J. Van Damme Gelatinase B functions as regulator and effector in leukocyte biology J. Leukoc. Biol., June 1, 2001; 69(6): 851 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jormsjo, S. Ye, J. Moritz, D. H. Walter, S. Dimmeler, A. M. Zeiher, A. Henney, A. Hamsten, and P. Eriksson Allele-Specific Regulation of Matrix Metalloproteinase-12 Gene Activity Is Associated With Coronary Artery Luminal Dimensions in Diabetic Patients With Manifest Coronary Artery Disease Circ. Res., May 12, 2000; 86(9): 998 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M MAYOSI, S. S KHOGALI, B. ZHANG, and H. WATKINS Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy J. Med. Genet., October 1, 1999; 36(10): 796 - 797. [Full Text]
|
|
|
|
|
|
S. J. Price, D. R. Greaves, and H. Watkins Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 Gene. ROLE OF Sp1 IN ALLELE-SPECIFIC TRANSCRIPTIONAL REGULATION J. Biol. Chem., March 2, 2001; 276(10): 7549 - 7558. [Abstract] [Full Text] [PDF]
|
|